JAMES MONTGOMERY: Open Payments
NPI 1568476182 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 77 payments from 17 companies in 2025. Trend: 2023 $667 · 2024 $1,139 · 2025 $2,038
Food & beverage: $1,925Education: $113
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $367 |
| GlaxoSmithKline, LLC. | 20 | $329 |
| CSL Behring | 10 | $281 |
| Grifols USA, LLC | 8 | $279 |
| Regeneron Healthcare Solutions, Inc. | 5 | $185 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Genentech USA, Inc. | 4 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| PFIZER INC. | 3 | $67 |
| GENZYME CORPORATION | 2 | $47 |
Products named: DUPIXENT, Xembify, TEZSPIRE, NUCALA, FASENRA, TRELEGY ELLIPTA, Haegarda, Xolair.
Industry payments across TN — which companies pay providers there.
